Brief: Affluent Medical Net Loss Widens To EUR 15.2 Mln

Carvolix SA

30/03/2023 17:21

March 30 (Reuters) - Affluent Medical SAS  AFME.PA :
    * 2022 RESULTS
    * NET RESULT 2022 LOSS 15.2 MILLION VERSUS LOSS EUR 14.8
MILLION
YEAR AGO
    * 2022 CURRENT OPERATING RESULT LOSS EUR 14.3 MILLION VERSUS
LOSS
EUR 13.2 MILLION YEAR AGO
    * THE LAST FUNDRAISING CARRIED OUT ON MARCH 6, 2023 ALLOWS
AFFLUENT MEDICAL TO EXTEND ITS CASH HORIZON UNTIL NOVEMBER 2023.
    * INTENDS TO SEEK NEW SOLUTIONS FOR FINANCING, IN PARTICULAR
THROUGH THE SETTING UP OF A VENTURE LOAN IN THE AMOUNT OF €6
MILLION FOR WHICH DISCUSSIONS HAVE BEEN INITIATED
    * COULD ALSO ENTER INTO PARTNERSHIPS FOR ITS KARDIOZIS
TECHNOLOGY
AND FOR ITS ARTUS, EPYGON OR KALIOSTM MEDICAL DEVICES ON THE
AMERICAN MARKET, WHICH WOULD BE A SOURCE OF REVENUE

Source text for Eikon:  ID:nEQ9NVw06a 
Further company coverage:  AFME.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))